MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising t

Article 223-16 of the General Regulations of the Financial Markets Authority (AMF - Autorité des Marchés Financiers)LYON, France--(BUSINESS WIRE)--$MAAT--Regulatory News:MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem Therap...

Related Keywords

France ,French ,Pauline Richaud ,Guilhaume Debroas ,Corporate Communications ,Regulations Of The Financial Markets Authority ,Trophic Communications ,General Regulations ,Financial Markets Authority ,Des March ,Regulatory News ,Microbiome Ecosystem ,French Commercial Code ,French Autorit ,Maat Pharma ,Microbiome Ecosystem Therapies ,Euronext Paris ,Investor Relations ,